U.S. flag An official website of the United States government
  1. Home
  2. Emergency Preparedness and Response
  3. Counterterrorism and Emerging Threats
  4. Coronavirus Disease 2019 (COVID-19)
  5. Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions
  1. Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions


Woman looking at computer with man in the background

The FDA is working with U.S. government partners including the Centers for Disease Control and Prevention (CDC), medical product manufacturers, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak. Find the most recent FDA updates on our Coronavirus Disease 2019 page.

These frequently asked questions are for a general public or consumer audience. Other audiences may want to refer to more detailed information:

General Information 

A: A novel coronavirus is a new coronavirus that has not been previously identified. The virus causing coronavirus disease 2019 (COVID-19) is not the same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.

Vaccines, Biologics, Human Tissues, and Blood Products

A: Biological products include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues.

Drugs (Medicines)

A: At this time, there are no FDA-approved drug products to treat COVID-19. The FDA is working with drug manufacturers and investigational new drug sponsors to expedite the development and availability of COVID-19 treatments. Read more about FDA’s actions to address the novel coronavirus with medical countermeasures.

Researchers are studying new drugs and drugs that are already approved for other health conditions as possible treatments for COVID-19. CDC has more information for health care providers about these potential treatments.

Medical Devices and Tests for COVID-19

A: Currently there is no FDA-approved or cleared test to diagnose or detect COVID-19 because the virus that causes COVID-19 is new. Therefore, the FDA has issued several Emergency Use Authorizations (EUAs) for the use of new diagnostic tests to detect the SARS-CoV-2 virus, which causes COVID-19. During public health emergencies declared under section 564 of the FD&C Act, the FDA is able to issue EUAs when certain criteria are met that allows for the use and distribution of potentially life-saving medical products to diagnose, treat, or prevent the disease, which can include diagnostic tests.

Food Products

A: There are no nationwide shortages of food, although in some cases the inventory of certain foods at your grocery store might be temporarily low before stores can restock. Food production and manufacturing are widely dispersed throughout the U.S. and there are currently no widespread disruptions reported in the supply chain. 

FDA is closely monitoring the food supply chain for any shortages in collaboration with industry and our federal and state partners. We are in regular contact with food manufacturers and grocery stores.

Animals, Pets and Animal Drug Products

A. According to the Centers for Disease Control and Prevention (CDC), there is no scientific evidence indicating that any animals in the United States, including pets, can spread COVID-19 or that they might be a source of infection in the United States. To date, there have been no reports of pets becoming sick with COVID-19.

The FDA is aware that more than one dog has tested positive for the virus that causes COVID-19, based on information from the Hong Kong Agriculture, Fisheries & Conservation Department. There is no evidence that companion animals, including pets, can spread COVID-19 or that they might be a source of infection in the United States.